Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.
Suzanne Jones, PharmD
Senior Director, Scientific Director, Strategic Development; Principal Investigator
Dr. Jones joined Sarah Cannon in 1998 and serves as the scientific director. Her responsibilities include the overall management of the institute's scientific portfolio, including novel agents, trial opportunities, publications and presentations as well as pharmaceutical and biotech relationships.
Jones received her undergraduate degree from the University of North Carolina at Chapel Hill in 1987 and her doctor of pharmacy degree from the University of North Carolina at Chapel Hill in 1989. She then completed her residency and fellowship in hematology/oncology at the Audie L. Murphy Veteran's Hospital and the University of Texas Health Science Center in San Antonio. Prior to joining Sarah Cannon Research Institute, Jones served as director, Investigational Drug Section at the Cancer Therapy and Research Center in San Antonio and as a senior clinical research scientist in Oncology Clinical Research at Glaxo Wellcome.